knowledge -WSS

knowledge

author：fashion 2025-09-27 09:55:17 - browse：2

Pascal Soriot - Senate Finance Committee — AstraZeneca CEO Pascal Soriot Jacquelyn Martin/AP

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.

Last week, Medicare made its first offers to the makers of the 10 products subject to negotiation, though it said it would be up to the companies to discuss the proposals. On Thursday, at a press briefing at which they presented their 2023 earnings, AstraZeneca executives also played coy about the bargaining over the price of the company’s diabetes drug Farxiga.

“We have received the first offer, but as you can imagine, we will not disclose what the offer is,” Ruud Dobber, the company’s executive vice president of biopharmaceuticals business, said at the event, held at the London Stock Exchange. “We are in active negotiation, and it will be a few rounds of discussions” with Medicare.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Ukraine taking heavy casualties 10 weeks into its counteroffensive

hotspot

WSS

Reports of telehealth's death have been greatly exaggerated

Study finds gene variants tied to breast cancer risk in Black women

Study finds gene variants tied to breast cancer risk in Black women

Fentanyl is making it harder to start addiction treatment

Evacuations in place as 3 wildfires burn in eastern Washington state

Digital health: a case of mistaken identity

entertainment

knowledge

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

UnitedHealth argues against case alleging wrongful AI care denials

Alkermes shareholders re

FDA poised to publish guidelines for clinical trial diversity

Sports medicine is finally prioritizing gender equality

New definition of a human embryo proposed amid rapid advances

New air purifier tech could be key to improving indoor air quality

The pain doctors face in trying to build their families

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Biogen joins immunology wave with $1.15 billion acquisition of HI

hotspot

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Biogen joins immunology wave with $1.15 billion acquisition of HI

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Eyeing GLP

FDA poised to publish guidelines for clinical trial diversity

hotspot

focus

focus

leisure time